MIAMI, FL / ACCESSWIRE / March 11, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. ATHX, ASTI, GBIM, and SSKN have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
Athersys, Inc. (NASDAQ: ATHX) is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. Athersys reported on Thursday its fourth-quarter net income of $3.6 million, after reporting a loss in the same period a year earlier. The stock has seen considerable volume and price appreciation in less than 2 months; increasing by as much as an addition $1 per share at times in comparison to previous prices in January. Friday (3/11) the stock posted new 11-month highs after hitting $2.20 in early morning trading.
Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here
Ascent Solar Technologies, Inc. (NASDAQ: ASTI) announced additional progress on its solar projects. The Company introduced two new high voltage-low current products specifically designed to address the needs of the high altitude aerospace market. The stock closed on Thursday (3/10) at $0.0575 and hit early morning highs on Friday (3/11) of $0.0845. Ascent Solar Technologies, Inc. is a developer of award winning thin-film photovoltaic modules with substrate materials that are more flexible, versatile and rugged than traditional solar panels. Ascent Solar modules can be directly integrated into consumer products and off-grid applications, as well as aerospace and building integrated applications. Members of record by 4PM March 11 will secure a place holder to receive our next report. Get Your Free Membership Now.
GlobeImmune Inc. (NASDAQ: GBIM) is a biopharmaceutical company focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform. Tarmogens activate the immune system by stimulating cellular immunity, known as T cell immunity, in contrast to traditional vaccines that predominately stimulate antibody production. Friday the stock climbed more than 100% with more than 1.3 million shares traded by 11:30AM EST.
Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word "NASDAQ" to 77948
STRATA Skin Sciences (NASDAQ: SSKN) announced Thursday (3/10) that the U.S. Food and Drug Administration approved STRATA’s PMA supplement for the MelaFind System. STRATA Skin Sciences is a medical technology company focused on the therapeutic and diagnostic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions, and the MelaFind® system used to assist in the identification and management of melanoma skin cancer. The stock climbed to highs of $1.53 and was up more than 30% from its previous close.
Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here
About TopNasdaqStocks.com
Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don't forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text "NASDAQ" to 77948.
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. Top Nasdaq Stocks has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures.
Contact:
Top Nasdaq Stocks
news@topnasdaqstocks.com
SOURCE: Top Nasdaq Stocks
